한독

002390KOSPI의약품 제조업

47.0 / 100

Reference Date: 2026-06-10

Financial Score15.0 / 40

News Sentiment19.0 / 25

Momentum3.0 / 20

Disclosure10.0 / 15

AI Analysis: PBR is significantly undervalued vs. peers but the high debt ratio poses financial risk. Plunged 22.5% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Han Dong, established in 1954, operates in pharmaceuticals, medical devices, health functional foods, and real estate leasing. Key products include Amaryl, Tenelria, and RediQ, with headquarters in Seoul's Gangnam-gu, a factory in Yongcheon, Chungcheongbuk, and a research institute in Gangseo-gu, Seoul. The company operates across multiple business segments.

Number of Employees

951people

Average Salary

78.0M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 11.934.0Point

PBR

0.38Industry Average 0.897.0Point

Half of industry avg (excellent)

ROE

-0.79Industry Average 4.010.0Point

Well below industry avg

Debt Ratio

34.98Industry Average 12.430.0Point

2.8x industry avg (risky)

Trend 2023~20254.0 / 10 points

Revenue Growth Rate

1.0 / 3

Avg ▲1.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲207.8% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -8.5% (improving, 3yr)

Detailed News Sentiment

5 totalPositive 4Neutral 1Negative 0Average Sentiment Score 76

Positive
한독 "고인슐린증 3상서 8명중 6명 1차지표 충족"
한독의 3상 임상 시험에서 주요 지표를 충족함으로써 종양 매개성 고인슐린증 치료제의 상용화 가능성이 높아졌다.
Positive
한독, ‘당당발걸음 캠페인-혈당 건강 습관 만들기’ 성료
한독의 '당당발걸음 캠페인' 성공으로 당뇨병 관리에 대한 인식 개선 및 참여 증가 기대.
Positive
[바이오톺아보기] ‘케토톱’ 한독, 헬스케어로 3세 경영 능력 시험대
한독의 장남이 대표이사로 취임하며 경영 승계와 확장 전략이 긍정적으로 평가됨.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 7,700Won52-week high 12,37052-week low 7,700

1-month return0.0Point

1m -22.46% (strong drop)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

10 totalPositive 0Neutral 10Negative 0

Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-04
Neutral주식등의대량보유상황보고서(일반)2026-06-04
Neutral최대주주등소유주식변동신고서2026-06-02
Neutral기업지배구조보고서공시2026-06-01
Neutral최대주주등소유주식변동신고서2026-06-01